UNSPSC 85532387: Supplement hepatic vein with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement hepatic vein with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06U407Z

UNSPSC 85532387 Supplement hepatic vein with autologous tissue substitute, open approach is a Commodity code that nominally describes a surgical procedure, but the recent state and local contract opportunities posted under this code show no alignment with hepatic vein supplementation or tissue-substitute surgical work. Instead, the opportunities span occupational medical surveillance, pharmacy benefit management, disability evaluation services, surgical benefit carve-outs for Centers of Excellence, temporary health professional staffing, and specialty emergency services for detained youth. The code appears to be a classification mismatch in the state and local procurement systems, with no concrete evidence that government jurisdictions are actually procuring hepatic vein surgical procedures under this taxonomy entry.

The geographic and issuing-body spread across the limited recent opportunities is scattered: the Washington State Department of Transportation (occupational surveillance across 14 ferry locations), the City of Phoenix Retirement Office (disability evaluations), the City of Long Beach (surgical benefits management), Harris County Juvenile Probation Department (emergency medical services), Collier County Board of County Commissioners (pharmacy benefit management), and the County of Santa Clara Health System (temporary health professional staffing). No clear pattern of repeat buyers or concentrated activity emerges. Given the absence of opportunities actually aligned with the code's stated scope, this UNSPSC code shows little relevant recent activity for vendors pursuing surgical implant or tissue-substitute procurement.